AB
BNGO icon

Amalgamated Bank’s Bionano Genomics BNGO Stock Holding History

Amalgamated Bank’s Portfolio BNGO Stock Details BNGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-51
Closed -$34K – 3045
2023
Q1 		$34K Sell
51
-13
-20% -$11.5K ﹤0.01% 2456
2022
Q4 		$56K Buy
64
+3
+5% +$3.77K ﹤0.01% 2368
2022
Q3 		$67K Hold
61
– – ﹤0.01% 2329
2022
Q2 		$51K Sell
61
-18
-23% -$18.5K ﹤0.01% 2468
2022
Q1 		$123K Sell
79
-6
-7% -$8.1K ﹤0.01% 2118
2021
Q4 		$152K Buy
85
+2
+2% +$5.35K ﹤0.01% 2009
2021
Q3 		$275K Sell
83
-6
-7% -$21K ﹤0.01% 1873
2021
Q2 		$389K Buy
+89
New +$351K ﹤0.01% 1771

Other funds holding BNGO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Qube Research & Technologies (QRT)
Qube Research & Technologies (QRT) London, United Kingdom $89.9B AUM 20.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $149B AUM 24.71% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Amalgamated Bank's BNGO Position: Q2 2023 in Review

Amalgamated Bank sold out of Bionano Genomics (BNGO) in Q2 2023, closing a stake of 51 shares — an estimated $34K sold.

Amalgamated Bank first reported a position in BNGO in Q2 2021 and held it in 8 quarters. The position peaked at $389K in Q2 2021. 108 funds tracked by Wall St. Rank hold BNGO as of Q2 2023.

  • Amalgamated Bank reported no remaining Bionano Genomics position as of Q2 2023 after selling out during the quarter.
  • Amalgamated Bank sold 51 Bionano Genomics shares in Q2 2023, an estimated $34K.
  • Amalgamated Bank first reported a position in Bionano Genomics in Q2 2021 and held it in 8 quarters.
  • Amalgamated Bank's Bionano Genomics position peaked at $389K in Q2 2021.
  • 108 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2023.

Based on Amalgamated Bank's 13F filing for Q2 2023, filed 11 Aug 2023.